SET and chronic myelogenous leukemia, BCR-ABL1 positive: SET expression is modestly affected in CML-CPCD34+ progenitors, but markedly upregulated in myeloid CML-BCCD34+ cells in which it correlates with loss of PP2A phosphatase activity (Neviani et al, 2005).